JPH0217180B2 - - Google Patents
Info
- Publication number
- JPH0217180B2 JPH0217180B2 JP18748686A JP18748686A JPH0217180B2 JP H0217180 B2 JPH0217180 B2 JP H0217180B2 JP 18748686 A JP18748686 A JP 18748686A JP 18748686 A JP18748686 A JP 18748686A JP H0217180 B2 JPH0217180 B2 JP H0217180B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- header
- hollow fiber
- center
- blood inlet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008280 blood Substances 0.000 claims description 103
- 210000004369 blood Anatomy 0.000 claims description 103
- 239000012510 hollow fiber Substances 0.000 claims description 41
- 230000007423 decrease Effects 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000009563 continuous hemofiltration Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
(産業上の利用分野)
本発明は改良された血液入口ヘツダを有する中
空繊維型血液処理装置に関するものである。
(従来の技術)
従来より中空繊維を用いた血液処理装置は、血
液透析装置、人工肝臓装置、血液濾過装置、血漿
分離装置、あるいは人工肺装置として広く用いら
れている。
このような血液処理装置(血液濾過装置)とし
て、通常第4図に示すような血液導入出口が軸対
称位置に設けられた装置が用いられている。
第4図において、1aは血液を中空繊維5の内
部に導き、かつ外部と隔離するための断面が円形
の血液入口ツダであり、血液はヘツダの上部に設
けた血液導入口20aよりヘツダ内に導入され
る。1bは中空繊維の内部を通過した血液を集合
させて血液導出口20bより導出するための断面
が円形の血液出口ヘツダである。2は血液の入口
及び出口ヘツダ1a,1bをパツキン12を介し
て、中空繊維束を固定する隔壁6に密着させるた
めの固定キヤツプである。ハウジング3は通常円
筒形であつて透明で硬質の合成樹脂(ポリプロピ
レン、ポリカーボネートなど)で作られ、その内
部には数百〜数万本程度の中空繊維5が充填され
ている。またこのハウジング3には、濾液導出口
4が設けられている。中空繊維5は、ハウジング
3内に多数本充填され、その両端はポリウレタン
樹脂などの血液適合性に優れた隔壁6で液密に固
定され、しかも中空繊維5の内部はヘツダ1a,
1bに設けられた空間と連通している。血液は血
液入口ヘツダ1aの血液導入口20aより装置内
に導入され中空繊維の壁膜を介して血液中の有害
物質をハウジング3の内部に排出した後、血液出
口ヘツダ1bの血液導出口2を経由して体内にも
どされる。一方、ハウジング3の内部に排出され
た有害物質は導出口4から外部へとり出される。
また、最近、各中空繊維に均一に血液を導入す
るために血液入口ヘツダに設けられた空間に接線
方向から血液を導入する血液処理装置が提案され
ている(特公昭60−5308号、特開昭57−86361号
など)。第5図は、かかる装置の例であり、図中
共通のものは第1図と同一番号が付されている。
この装置では血液は血液入口ヘツダ1aの外部か
ら内部へ向けて接線方向に開口した血液導入口2
0aより導入されヘツダ内に設けられた空間の上
端の内壁面に沿つてラセン状に設けられた血液誘
導路10にそつて旋回しながら下降し、中空繊維
束の切断面の外周部に達し、次いで中心に向かう
ラセン流となつて切断面から各中空繊維内部に導
入されるようになつている。
(発明が解決しようとする問題点)
しかしながら、このような従来の血液処理装置
には次のような欠点があり、特にヘパリンのよう
な抗血液凝固剤を全く使用しないか、あるいは使
用量を減らした血液透析(ノンヘパあるいは減ヘ
パ透析)や、持続的血液濾過(CAVH)、体外循
環肺補助(ECMO)などの数日におよぶ長期使
用の場合においては実用上種々の問題がある。す
なわ第4図に示す血液処理装置では構造上、血液
導入口20aより導入された血液は、まず中空繊
維の端面中央部に衝突し、次いで外周部の中空繊
維へ分散される。従つてヘツダの内部の中間を流
れる血液の速度は、血液の導入口の直下付近では
大きく、周辺に向うに従つて小さくなる。その結
果ヘツダの空間内で血液のよどみを生じ、またヘ
ツダに設けられた空間の週辺部では、血液が停滞
する恐れがある。そのため血液処理装置としての
性能が低下し、しかも返血する際に、返血速度が
中央部と周辺部で異なるため、周辺部に近い中空
繊維の内部や、血液がよどみをつくつた領域に残
血現象を起こす。一方、第5図に示す装置では、
中空繊維の切断面において相対的に広い面積を占
める外周部に対して接線方向から血液が導かれ、
その後、ラセン流路の厚みが漸減するために外周
部と内周部の中空繊維内部への血液流入速度は第
4図に示す装置よりは均一に保たれ、かつ、切断
面に対して平行な血流速度も大きな値をとり得
る。しかしヘツダに設けられた空間での血液の流
れは、固定された流路でないため、ラセン流路を
とるものの、ハウジングに収容された中空繊維の
分布状態や、中空繊維の切断面の起伏、ヘツダの
血液との接触面の起伏の状態によつてかえつて部
分的なうず流と、それに伴う血栓形成および気泡
の滞留を起し易く、しかもヘツダがかさ高くなる
ため血液充填量が増加するなどの問題があつた。
(問題点を解決するための手段)
従つて本発明の目的は気泡の滞留や血栓、血餅
の発生が少なく、長時間連続使用しても中空繊維
の閉塞が起こらないような血液入口ヘツダを有す
る血液処理装置を提供することにある。
すなわち本発明は一端に血液入口ヘツダと、他
端に血液出口ヘツダを備えた筒状ハウジング内に
中空繊維束が収容された中空繊維型血液処理装置
であつて、該血液入口ヘツダの内部に溝壁の頂部
が中空繊維束の切断面に実質的に当接し、かつヘ
ツダの中心部の手前まで連続ラセン状溝を延在さ
せて、該ヘツダの中心部に空間を設けるととも
に、該連続ラセン状溝の端部に接線方向に開口す
る血液導入口を設けて、該血液入口から血液入口
ヘツダ内に導入された血液をラセン状溝に沿つて
ヘツダ中心部に形成された空間内に流入させるよ
う構成したことを特徴とする中空繊維型血液処理
装置である。
(作用)
本発明の血液処理装置は、血液入口ヘツダの内
部にヘツダの中心部の手前まで延在された連続ラ
セン状溝が設けられているので、血液導入口から
ヘツダ内部に導入された血液は、該連続ラセン状
溝に沿つてラセン状に旋回しつつ、ヘツダの中部
部に設けられた空間内に流入させることができ
る。そのためラセン状溝をヘツダの中心部の手前
まで延在させたときのヘツダ中心部での血液量の
極端な減少が防止され全ての中空繊維に血液を一
様に導入することができる。そのため、中空繊維
束の開口端面上における気泡の滞留や血栓形成の
原因となるよどみ、血小板の粘着の抑止や、中空
糸の閉塞を解消できるものと推測される。
(実施例)
次に本発明の血液処理装置の一実施例を図面に
よつて説明する。第1図は本発明装置の一部断面
図、第2図は連続ラセン状溝の溝の深さがヘツダ
中心部に向かつて漸減してい場合の血液入口ヘツ
ダ1aの斜視図であり、図中共通のものは第4図
と同一番号が付されている。第1図の装置はヘツ
ダ部分を中心とした構造に特徴がある。本発明装
置では血液入口ヘツダ1aの血液導入口20aよ
り導入された血液は、ヘツダ内側の中心から周辺
部に延在する連続ラセン状壁7で形成された連続
ラセン溝8の端部へ接線方向から導入される。該
連続ラセン状壁7の頂部は第1図に示すように中
空繊維の切断面に実質的に当接するため、血液導
入口20aよりヘツダ内に導入された血液は連続
ラセン状溝8を移動しながら、中空繊維内部に導
入される。また、ラセン状溝8はヘツダの中心部
の手前まで延在されて、ヘツダの中心部に空間9
が形成されているため、血液をヘツダの中心部へ
流入させることができる。かかるヘツダ中心部の
空間の直径は通常ヘツダ内側の直径の1/6〜1/3と
することが好ましい。従つて、各中空繊維にはほ
ぼ均一に血液が導入される。しかしながら、ラセ
ン状壁の頂部が中空繊維の切断面に当接するた
め、その部分の中空繊維には血液が流れない。そ
のためラセン状壁の頂部は鋭く細くするのが好ま
しい。上記ラセン状溝の深さを第2図に示すよう
に除々に小さくすると、連続ラセン状溝の全ての
場所において血液の速度を一定とすることができ
るため好ましい。
また血液出口ヘツダ1bも入口ヘツダ1aと同
様に、血液導出口20bをヘツダの接線方向に設
けると、装置の長さ方向の寸法を小とすることが
できるので、コンパクトになり、望ましい。その
際には血液出口ヘツダ1bの凹所にはラセン状壁
を設けないほうが好ましい。
次に本発明装置と従来装置との性能の比較を行
う。
本発明装置として血液入口ヘツダに第1図に示
すようなヘツダの中心部の手前まで延在された連
続ラセン状溝を有し、血液出口ヘツダにはラセン
状溝を設けない装置を用いた。一方、従来装置と
して第4図と第5図に示す装置を用いた。(内径
235μmのポリスルホン膜を使用、中空糸本数
4300本、有効膜面積0.5m2)
上記各血液処理装置に牛新鮮血(ヘマトクリツ
ト値38%、全蛋白質濃度6g/dl)を用い、血液
流速200ml/min、膜間圧力差100mmHgの条件で
血液濾過試験を行つた。8時間血液濾過後の限外
濾過量および返血後の残血本数について測定した
結果を表1に示す。
INDUSTRIAL APPLICATION This invention relates to a hollow fiber blood processing device having an improved blood inlet header. (Prior Art) Blood processing devices using hollow fibers have conventionally been widely used as hemodialysis devices, artificial liver devices, blood filtration devices, plasma separation devices, or artificial lung devices. As such a blood processing device (blood filtration device), a device in which blood inlet ports are provided at axially symmetrical positions as shown in FIG. 4 is usually used. In FIG. 4, 1a is a blood inlet tube with a circular cross section for guiding blood into the inside of the hollow fiber 5 and isolating it from the outside. be introduced. Reference numeral 1b denotes a blood outlet header having a circular cross section for collecting blood that has passed through the hollow fibers and leading it out from the blood outlet 20b. Reference numeral 2 designates a fixing cap for bringing the blood inlet and outlet headers 1a and 1b into close contact with the partition wall 6, which fixes the hollow fiber bundle, through the packing 12. The housing 3 is usually cylindrical and made of transparent, hard synthetic resin (polypropylene, polycarbonate, etc.), and its interior is filled with hundreds to tens of thousands of hollow fibers 5. The housing 3 is also provided with a filtrate outlet 4. A large number of hollow fibers 5 are packed in the housing 3, and both ends of the hollow fibers 5 are fixed liquid-tightly with partition walls 6 made of polyurethane resin or the like having excellent blood compatibility.
It communicates with the space provided in 1b. Blood is introduced into the device through the blood inlet port 20a of the blood inlet header 1a, and harmful substances in the blood are discharged into the housing 3 through the wall membrane of the hollow fibers. It is returned to the body via On the other hand, harmful substances discharged into the interior of the housing 3 are taken out from the outlet 4. Recently, a blood processing device has been proposed in which blood is introduced tangentially into a space provided in a blood inlet header in order to introduce blood uniformly into each hollow fiber (Japanese Patent Publication No. 60-5308, (Sho 57-86361, etc.) FIG. 5 shows an example of such a device, and common parts in the figure are given the same numbers as in FIG. 1.
In this device, blood is introduced into a blood inlet port 2 which opens tangentially from the outside to the inside of the blood inlet header 1a.
It is introduced from 0a and descends while turning along the blood guide path 10 provided in a spiral shape along the inner wall surface of the upper end of the space provided in the header, and reaches the outer periphery of the cut surface of the hollow fiber bundle. Then, it becomes a spiral flow toward the center and is introduced into each hollow fiber from the cut surface. (Problems to be Solved by the Invention) However, such conventional blood processing devices have the following drawbacks. There are various practical problems in the case of long-term use over several days, such as hemodialysis (non-hepadialysis or reduced hepadialysis), continuous hemofiltration (CAVH), and extracorporeal circulation pulmonary support (ECMO). That is, in the blood processing apparatus shown in FIG. 4, due to the structure, blood introduced from the blood inlet 20a first collides with the center of the end face of the hollow fiber, and then is dispersed into the hollow fiber at the outer periphery. Therefore, the speed of blood flowing in the middle of the header is high near the area immediately below the blood inlet, and decreases toward the periphery. As a result, blood may stagnate within the space of the header, and blood may stagnate on the side of the space provided in the header. As a result, the performance of the blood processing device deteriorates, and when blood is returned, the speed of blood return differs between the center and the periphery, so blood remains inside the hollow fibers near the periphery or in areas where blood stagnates. Causes blood phenomena. On the other hand, in the device shown in FIG.
Blood is guided from the tangential direction to the outer periphery, which occupies a relatively large area on the cut surface of the hollow fiber,
After that, since the thickness of the helical flow path gradually decreases, the velocity of blood flowing into the hollow fiber at the outer and inner circumferences is kept more uniform than in the device shown in Figure 4, and is parallel to the cutting surface. Blood flow velocity can also take on large values. However, the flow of blood in the space provided in the header is not a fixed flow path, and although it takes a helical flow path, the distribution of the hollow fibers accommodated in the housing, the undulations of the cut surface of the hollow fibers, and the Depending on the undulations of the contact surface with the blood, local eddy flow and associated thrombus formation and bubble retention may occur more easily, and the volume of blood filling increases as the head becomes bulkier. There was a problem. (Means for Solving the Problems) Therefore, the object of the present invention is to provide a blood inlet header which has less accumulation of air bubbles, less occurrence of thrombi, and less blood clots, and which does not cause blockage of hollow fibers even when used continuously for a long time. An object of the present invention is to provide a blood processing device having the following features. That is, the present invention is a hollow fiber type blood processing device in which a hollow fiber bundle is housed in a cylindrical housing having a blood inlet header at one end and a blood outlet header at the other end, the blood inlet header having a groove inside. The top of the wall substantially abuts the cut surface of the hollow fiber bundle, and a continuous helical groove extends in front of the center of the header to provide a space in the center of the header, and the continuous helical groove extends in front of the center of the header. A blood inlet opening in the tangential direction is provided at the end of the groove so that blood introduced from the blood inlet into the blood inlet header flows into the space formed in the center of the header along the spiral groove. This is a hollow fiber type blood processing device characterized by the following configuration. (Function) The blood processing device of the present invention is provided with a continuous helical groove extending to the front of the center of the header inside the blood inlet header, so that blood introduced into the header from the blood inlet can be made to flow into the space provided in the central portion of the header while turning in a helical manner along the continuous helical groove. Therefore, when the helical groove is extended to the front of the center of the header, an extreme decrease in the amount of blood at the center of the header is prevented, and blood can be uniformly introduced into all the hollow fibers. Therefore, it is presumed that stagnation that causes accumulation of air bubbles and thrombus formation on the open end surface of the hollow fiber bundle, inhibition of platelet adhesion, and occlusion of the hollow fibers can be eliminated. (Example) Next, an example of the blood processing apparatus of the present invention will be described with reference to the drawings. FIG. 1 is a partial sectional view of the device of the present invention, and FIG. 2 is a perspective view of the blood inlet header 1a in which the depth of the continuous spiral groove gradually decreases toward the center of the header. Common parts are given the same numbers as in FIG. The device shown in FIG. 1 is characterized by its structure centered around the header portion. In the device of the present invention, blood introduced from the blood inlet 20a of the blood inlet header 1a is directed tangentially to the end of a continuous helical groove 8 formed by a continuous helical wall 7 extending from the center inside the header to the periphery. introduced from. As the top of the continuous helical wall 7 substantially contacts the cut surface of the hollow fiber as shown in FIG. while being introduced inside the hollow fiber. Further, the spiral groove 8 extends to the front of the center of the header, and a space 9 is formed in the center of the header.
, which allows blood to flow into the center of the header. The diameter of the space at the center of the header is usually preferably 1/6 to 1/3 of the inner diameter of the header. Therefore, blood is introduced into each hollow fiber almost uniformly. However, since the top of the helical wall abuts the cut surface of the hollow fiber, blood does not flow into the hollow fiber at that portion. Therefore, it is preferable that the top of the helical wall be sharp and narrow. It is preferable to gradually reduce the depth of the helical groove as shown in FIG. 2 because the blood velocity can be kept constant at all locations in the continuous helical groove. Further, it is preferable that the blood outlet header 1b is also provided with the blood outlet 20b in the tangential direction of the header, as in the case of the inlet header 1a, since this makes it possible to reduce the lengthwise dimension of the apparatus, thereby making it more compact. In this case, it is preferable not to provide a helical wall in the recess of the blood outlet header 1b. Next, the performance of the device of the present invention and the conventional device will be compared. As the device of the present invention, the blood inlet header has a continuous helical groove extending to the front of the center of the header as shown in FIG. 1, and the blood outlet header does not have a helical groove. On the other hand, devices shown in FIGS. 4 and 5 were used as conventional devices. (inner diameter
Uses 235μm polysulfone membrane, number of hollow fibers
4300 tubes, effective membrane area 0.5 m 2 ) Fresh bovine blood (hematocrit value 38%, total protein concentration 6 g/dl) was used in each of the above blood processing devices, and the blood flow rate was 200 ml/min and the transmembrane pressure difference was 100 mmHg. A filtration test was conducted. Table 1 shows the results of measuring the amount of ultrafiltration after 8-hour hemofiltration and the number of blood remaining after blood return.
【表】
以上の結果から、本発明の装置は従来装置に比
較して、限外濾過量は多く、また残血本数は極度
に少ないことが明らかである。さらに肉眼での観
察の結果、本発明の血液処理装置ではヘツダに導
入された血液が、ほぼ均一に各中空繊維に導入さ
れていることが確認された。
従つて、本発明の血液処理装置は長時間連続し
て使用される体外循環肺補助や持続的血液濾過、
あるいは減ヘパリン透析などに好適に用いられ
る。
(発明の効果)
以上のように、本発明の血液処理装置は、ヘツ
ダ内側に血液を誘導する連続ラセン状溝が、該ラ
セン状溝のヘツダ内中心部において、空間が存在
するように設けられているので、中空繊維束の開
口端面に平行な血液速度を好適に維持することが
できる。かかる構造は中空繊維内部への血液流入
速度に与える影響を少なくすることができ、従つ
て、本発明の血液処理装置においては、ほぼ均一
な流入速度が得られるため、ヘツド内凹所での気
泡の滞留、血栓や血餅の発生の抑止効果が強く発
現し、従来装置では不可能であつた、長時間連続
使用や、ノンヘパ、減ヘパ透析が可能である。[Table] From the above results, it is clear that the device of the present invention has a larger amount of ultrafiltration and an extremely smaller number of residual blood tubes than the conventional device. Furthermore, as a result of visual observation, it was confirmed that in the blood processing apparatus of the present invention, the blood introduced into the header was almost uniformly introduced into each hollow fiber. Therefore, the blood processing device of the present invention can be used for extracorporeal circulation pulmonary support or continuous hemofiltration that is used continuously for a long time.
Alternatively, it is suitably used for reduced heparin dialysis. (Effects of the Invention) As described above, in the blood processing device of the present invention, the continuous spiral groove for guiding blood inside the header is provided such that a space exists at the center of the spiral groove inside the header. Therefore, the blood velocity parallel to the open end surface of the hollow fiber bundle can be suitably maintained. Such a structure can reduce the influence on the blood inflow speed into the hollow fiber, and therefore, in the blood processing device of the present invention, a substantially uniform inflow speed can be obtained, so that air bubbles in the recesses in the head can be reduced. It has a strong effect of inhibiting the retention of blood and the generation of thrombi and blood clots, and enables long-term continuous use and non-hepatodialysis and low-hepadialysis, which was impossible with conventional devices.
第1図は本発明の血液処理装置の一部断面図で
あり、第2図は連続ラセン状溝の溝の深さがヘツ
ダ中心部に向つて漸減している場合のヘツダの断
面図であり、第3図は本発明の装置のヘツダ部形
状を拡大した斜視図であり、第4図及び第5図は
従来の血液処理装置の一部断面図である。
1a,1b……血液入口、出口ヘツダ、2……
固定キヤツプ、3……ハウジング、4……濾液導
出口、5……中空繊維、6……隔壁、7……連続
ラセン状壁、8……連続ラセン状溝。
FIG. 1 is a partial sectional view of the blood processing device of the present invention, and FIG. 2 is a sectional view of a header in which the depth of the continuous spiral groove gradually decreases toward the center of the header. , FIG. 3 is an enlarged perspective view of the shape of the header portion of the device of the present invention, and FIGS. 4 and 5 are partial sectional views of a conventional blood processing device. 1a, 1b...Blood inlet, outlet header, 2...
Fixed cap, 3... Housing, 4... Filtrate outlet, 5... Hollow fiber, 6... Partition wall, 7... Continuous helical wall, 8... Continuous helical groove.
Claims (1)
ツダを備えた筒状ハウジング内に中空繊維束が収
容された中空繊維型血液処理装置であつて、該血
液入口ヘツダの内部に溝壁の頂部が中空繊維束の
切断面に実質的に当接し、かつヘツダの中心部の
手前まで連続ラセン状溝を延在させて、該ヘツダ
の中心部に空間を設けるとともに、該連続ラセン
状溝の端部に接線方向に開口する血液導入口を設
けて、該血液入口から血液入口ヘツダ内に導入さ
れた血液をラセン状溝に沿つてヘツダ中心部に形
成された空間内に流入させるよう構成したことを
特徴とする中空繊維型血液処理装置。1 A hollow fiber blood processing device in which a hollow fiber bundle is housed in a cylindrical housing having a blood inlet header at one end and a blood outlet header at the other end, the top of the groove wall inside the blood inlet header. substantially abuts the cut surface of the hollow fiber bundle, and extends a continuous helical groove to the front of the center of the header to provide a space in the center of the header, and the end of the continuous helical groove A blood inlet opening in the tangential direction is provided in the blood inlet header, and the blood introduced from the blood inlet into the blood inlet header is configured to flow into a space formed in the center of the header along a spiral groove. A hollow fiber type blood processing device featuring:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18748686A JPS6343671A (en) | 1986-08-08 | 1986-08-08 | Hollow fiber type blood treatment apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18748686A JPS6343671A (en) | 1986-08-08 | 1986-08-08 | Hollow fiber type blood treatment apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6343671A JPS6343671A (en) | 1988-02-24 |
| JPH0217180B2 true JPH0217180B2 (en) | 1990-04-19 |
Family
ID=16206908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18748686A Granted JPS6343671A (en) | 1986-08-08 | 1986-08-08 | Hollow fiber type blood treatment apparatus |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6343671A (en) |
-
1986
- 1986-08-08 JP JP18748686A patent/JPS6343671A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6343671A (en) | 1988-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100649260B1 (en) | Dual-stage filtration cartridge | |
| KR101099962B1 (en) | Fluid distribution module and extracorporeal blood circuit comprising such fluid distribution module | |
| CA2544612C (en) | Degassing device and end-cap assembly for a filter including such a degassing device | |
| CN100586494C (en) | Integrated blood processing module | |
| US4125468A (en) | Hollow-fiber permeability apparatus | |
| CA1089370A (en) | Hollow fiber permeability apparatus | |
| US4231877A (en) | Blood dialyzer | |
| JPH01148266A (en) | Blood filter | |
| US3373876A (en) | Artificial body organ apparatus | |
| JPH0217179B2 (en) | ||
| JPH0217180B2 (en) | ||
| JPH0217181B2 (en) | ||
| JPS644789B2 (en) | ||
| JPS6030224B2 (en) | Blood processing device with hollow fiber membrane bundle | |
| JPS605308B2 (en) | Blood processing device consisting of hollow fiber membrane bundle | |
| JP2005118506A (en) | On-line massive fluid replacement type hemodialyzer | |
| JPS6323099Y2 (en) | ||
| JPH09108338A (en) | Blood port and blood processing apparatus using the same | |
| GB2077621A (en) | Dialysing and ultra-filtering device | |
| JP2000042100A (en) | Hollow fiber membrane type liquid treatment apparatus | |
| JPH01151908A (en) | Hollow yarn type fluid processor | |
| JPH0550299B2 (en) | ||
| JPH0550300B2 (en) | ||
| JPH0229961Y2 (en) | ||
| JPS609820B2 (en) | Hollow fiber membrane mass transfer device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |